311 related articles for article (PubMed ID: 24534264)
21. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Sex Differences in the Initial Symptom Burden, Applied Treatment Strategy, and Quality of Life in Japanese Patients With Atrial Fibrillation.
Ikemura N; Kohsaka S; Kimura T; Ueda I; Katsumata Y; Nishiyama T; Aizawa Y; Tanimoto K; Momiyama Y; Akaishi M; Mitamura H; Fukuda K; Spertus JA; Takatsuki S
JAMA Netw Open; 2019 Mar; 2(3):e191145. PubMed ID: 30924896
[TBL] [Abstract][Full Text] [Related]
23. Cohort profile: patient characteristics and quality-of-life measurements for newly-referred patients with atrial fibrillation-Keio interhospital Cardiovascular Studies-atrial fibrillation (KiCS-AF).
Ikemura N; Spertus JA; Kimura T; Mahaffey K; Piccini JP; Inohara T; Ueda I; Tanimoto K; Suzuki M; Nakamura I; Akaishi M; Mitamura H; Fukuda K; Takatsuki S; Kohsaka S
BMJ Open; 2019 Dec; 9(12):e032746. PubMed ID: 31857312
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
Spertus J; Dorian P; Bubien R; Lewis S; Godejohn D; Reynolds MR; Lakkireddy DR; Wimmer AP; Bhandari A; Burk C
Circ Arrhythm Electrophysiol; 2011 Feb; 4(1):15-25. PubMed ID: 21160035
[TBL] [Abstract][Full Text] [Related]
25. Symptom Burden of Atrial Fibrillation and Its Relation to Interventions and Outcome in Europe.
Schnabel RB; Pecen L; Rzayeva N; Lucerna M; Purmah Y; Ojeda FM; De Caterina R; Kirchhof P
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776959
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in symptoms and functional status in patients with atrial fibrillation undergoing catheter ablation.
Bazemore TC; Bolger LE; Sears SF; Sadaf MI; Gehi AK
Pacing Clin Electrophysiol; 2019 Feb; 42(2):224-229. PubMed ID: 30548873
[TBL] [Abstract][Full Text] [Related]
27. Symptom Under-Recognition of Atrial Fibrillation Patients in Consideration for Catheter Ablation: A Report From the KiCS-AF Registry.
Katsumata Y; Kohsaka S; Ikemura N; Ueda I; Hashimoto K; Yamashita T; Miyama H; Fujisawa T; Kimura T; Tanimoto K; Momiyama Y; Suzuki M; Fukuda K; Takatsuki S
JACC Clin Electrophysiol; 2021 May; 7(5):565-574. PubMed ID: 33358669
[TBL] [Abstract][Full Text] [Related]
28. Baseline Health Status and its Association With Subsequent Cardiovascular Events in Patients With Atrial Fibrillation.
Ikemura N; Spertus JA; Nguyen DD; Kimura T; Katsumata Y; Fu Z; Jones PG; Niimi N; Shoji S; Ueda I; Tanimoto K; Suzuki M; Fukuda K; Takatsuki S; Kohsaka S
JACC Clin Electrophysiol; 2023 Sep; 9(9):1934-1944. PubMed ID: 37498250
[TBL] [Abstract][Full Text] [Related]
29. Improvement in the quality of life of patients with persistent or long-standing persistent atrial fibrillation after hybrid ablation.
Osmancik P; Budera P; Talavera D; Herman D; Vesela J; Prochazkova R; Rizov V; Kacer P
J Interv Card Electrophysiol; 2020 Apr; 57(3):435-442. PubMed ID: 31001766
[TBL] [Abstract][Full Text] [Related]
30. New classification scheme for atrial fibrillation symptom severity and burden.
Koci F; Forbes P; Mansour MC; Heist EK; Singh JP; Ellinor PT; Ruskin JN
Am J Cardiol; 2014 Jul; 114(2):260-5. PubMed ID: 24878121
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of quality of life in atrial fibrillation on patient value.
Theunissen LJHJ; van de Pol JAA; van Steenbergen GJ; Cremers HP; van Veghel D; van der Voort PH; Polak PE; de Jong SFAMS; Seelig J; Smits G; Kemps HMC; Dekker LRC
Health Qual Life Outcomes; 2023 Apr; 21(1):33. PubMed ID: 37016364
[TBL] [Abstract][Full Text] [Related]
32. Relationship between quality of life and burden of recurrent atrial fibrillation following ablation: CAPCOST multicentre cohort study.
Essebag V; Azizi Z; Alipour P; Khaykin Y; Leong-Sit P; Sarrazin JF; Sturmer M; Morillo C; Terricabras M; Amit G; Roux JF; Patterson S; Verma A
Europace; 2020 Jul; 22(7):1017-1025. PubMed ID: 32531030
[TBL] [Abstract][Full Text] [Related]
33. Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
Bisson A; Bodin A; Clementy N; Bernard A; Babuty D; Lip GYH; Fauchier L
Int J Cardiol; 2018 Jun; 260():93-98. PubMed ID: 29540261
[TBL] [Abstract][Full Text] [Related]
34. [Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study].
Kirch W; Pittrow D; Bosch RF; Kohlhaussen A; Willich SN; Rosin L; Bonnemeier H;
Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S26-32. PubMed ID: 20221975
[TBL] [Abstract][Full Text] [Related]
35. Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.
Kotecha D; Bunting KV; Gill SK; Mehta S; Stanbury M; Jones JC; Haynes S; Calvert MJ; Deeks JJ; Steeds RP; Strauss VY; Rahimi K; Camm AJ; Griffith M; Lip GYH; Townend JN; Kirchhof P;
JAMA; 2020 Dec; 324(24):2497-2508. PubMed ID: 33351042
[TBL] [Abstract][Full Text] [Related]
36. Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.
Arribas F; Ormaetxe JM; Peinado R; Perulero N; Ramírez P; Badia X
Europace; 2010 Mar; 12(3):364-70. PubMed ID: 20056594
[TBL] [Abstract][Full Text] [Related]
37. Effect of Compliance to Updated AHA/ACC Performance and Quality Measures Among Patients With Atrial Fibrillation on Outcome (from Japanese Multicenter Registry).
Inohara T; Kimura T; Ueda I; Ikemura N; Tanimoto K; Nishiyama N; Aizawa Y; Nishiyama T; Katsumata Y; Fukuda K; Takatsuki S; Kohsaka S
Am J Cardiol; 2017 Aug; 120(4):595-600. PubMed ID: 28651850
[TBL] [Abstract][Full Text] [Related]
38. [Impacts of radiofrequency ablation on quality of life of atrial fibrillation patients with low CHA2DS2-VASc score].
Bai Y; Liu N; Bai R; Wu JH; Shi XB; Liu XY; Liu XH; Du X; Dong JZ; Ma CS
Zhonghua Nei Ke Za Zhi; 2016 Apr; 55(4):278-82. PubMed ID: 27030615
[TBL] [Abstract][Full Text] [Related]
39. Temporal pattern/episode duration-based classification of atrial fibrillation as paroxysmal vs. persistent: is it time to develop a more integrated prognostic score to optimize management?
Hammond-Haley M; Providência R; Lambiase PD
Europace; 2018 Nov; 20(FI_3):f288-f298. PubMed ID: 29016766
[TBL] [Abstract][Full Text] [Related]
40. Impact of COVID-19 on patients awaiting ablation for atrial fibrillation.
Pius C; Ahmad H; Snowdon R; Ashrafi R; Waktare JE; Borbas Z; Luther V; Mahida S; Modi S; Hall M; Gupta D; Todd D
Open Heart; 2022 Jun; 9(1):. PubMed ID: 35697474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
